A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions

Vox Sanguinis

Volumn 113, Issue 2, 2018, Pages 160-169

  Gehrie, E A ^a   Roubinian, N H ^b,c   Chowdhury, D ^d   Brambilla, D J ^d   Murphy, E L ^b,c   Gottschall, J L ^e,f   Wu, Y ^g,h   Ness, P M ^a   Strauss, R G ⁱ   Hendrickson, J E ^g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d RTI INTERNATIONAL   (United States)

^e BLOOD RESEARCH INSTITUTE   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g YALE UNIVERSITY   (United States)

^h BloodWorks Northwest   (United States)

ⁱ INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

Author keywords

blood safety; patient blood management; transfusion reactions

Indexed keywords

ADULT; ALLERGIC REACTION; ARTICLE; BLOOD COMPONENT THERAPY; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BODY TEMPERATURE; BREATHING RATE; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; FEVER; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT REPEATABILITY; MEDICAL EXPERT; MEDICAL RECORD REVIEW; NURSE; PLASMA TRANSFUSION; PRIORITY JOURNAL; PULSE RATE; RETROSPECTIVE STUDY; SHOCK; SYSTOLIC BLOOD PRESSURE; TERTIARY CARE CENTER; THROMBOCYTE TRANSFUSION; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY; UNITED STATES; VITAL SIGN; CLINICAL TRIAL; MULTICENTER STUDY; PROCEDURES; STANDARDS;

BLOOD TRANSFUSION; HUMANS; TRANSFUSION REACTION; VITAL SIGNS;

EID: 85038932538     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12621     Document Type: Article

References (18)

1. Whitaker BI, Rajbhandary SR, Harris A: The 2013 AABB Blood Collection, Utilization and Patient Blood Management Survey Report. AABB Press, 2015. Available at: http://www.aabb.org/research/hemovigilance/bloodsurvey/Docs/2013-AABB-Blood-Survey-Report.pdf. [Last accessed 23 January 2017]
2. Bolton-Maggs PHB (Ed): D Poles et al. on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2015 Annual SHOT Report, 2016. Available at: http://www.shotuk.org/wp-content/uploads/SHOT-2015-Annual-Report-Web-Edition-Final-bookmarked-1.pdf. [Last accessed 29 July 2016]
3. Hendrickson JE, Roubinian NH, Chowdhury D, et al.: Incidence of transfusion reactions: a multi-center study utilizing systematic active surveillance and expert adjudication. Transfusion 2016; 56:2587–2596
4. King KE, Shirey S, Thoman SK, et al.: Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004; 44:25–29
5. U.S. Centers for Disease Control and Prevention: The National Healthcare Safety Network (NHSN) Manual: Biovigilance Component v2.2. Atlanta, GA: Division of Healthcare Quality Promotion, National Center for Emerging Zoonotic Infectious Diseases: Available at: http://www.cdc.gov/nhsn/pdfs/biovigilance/bv-hv-protocol-current.pdf. [Last accessed 29 July 2016]
6. AABB: Standards for Blood Banks and Transfusion Services, 30th edn. Bethesda, MD: AABB Press, 2016:89
7. Gehrie EA, Hendrickson JE, Tormey CA: Variation in vital signs resulting from blood component administration in adults. Transfusion 2015; 55:1866–1871
8. Gehrie EA, Hendrickson JE, Tormey CA: Measuring the influence of blood component infusion rate on recipient vital signs. Vox Sang 2015; 109:353–358
9. Andrzejewski C, Popovsky MA, Stec TC, et al.: Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects? Transfusion 2012; 52:2310–2320
10. Andrzejewski C, Steingrub J, Nathanson BH, et al.: Statistical analysis of vital sign value changes in patients undergoing uncomplicated transfusions. Transfusion 2004; 44:35a. Available at: http://onlinelibrary.wiley.com/doi/10.1111/j.0041-1132.2004.449_5.x/epdf
11. Andrzejewski CM, McGirr J: Evaluation and management of suspected transfusion reactions: nursing perspectives; in: Popovsky MA (ed): Transfusion reactions. Bethesda, MD, AABB Press, 2007:525–547
12. NHSN. Biovigilance Component: Hemovigilance Module Surveillance Protocol v2.2. CDC. Available from: www.cdc.gov/nhsn. [Last accessed 9 September 2017]
13. Chung KW, Harvey A, Basavaraju SV, et al.: How is national recipient hemovigilance conducted in the United States? Transfusion 2015; 55:703–707
14. ISBT Working Party on Haemovigilance: Proposed Standard Definitions for Surveillance of Non Infectious Adverse Transfusion Reactions. ISBT and the International Haemovigilance Network, 2011
15. Tinegate H, Birchall J, Gray A, et al.: Guidelines on the investigation and management of acute transfusion reactions prepared by the BCSH blood transfusion task force. Br J Haematology 2012; 159:143–153
16. Lieberman L, Maskens C, Cserti-Gazdewich C, et al.: A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion associated circulatory overload. Transfus Med Rev 2013; 27:206–212
17. Parmar N, Pendergrast J, Lieberman L, et al.: The association of fever with transfusion-associated circulatory overload. Vox Sang 2017; 112:70–78
18. Cohen R, Escorcia A, Tasmin F, et al.: Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions. Transfusion 2017; 57:1674–1683